See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Stephanie Carlin

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	39581233	0	Carlin S, Chan N, Godoy A, et al. JTH in Clinic - Choosing the optimal oral anticoagulant for stroke prevention in atrial fibrillation: direct oral anticoagulants vs. vitamin K antagonists. J Thromb Haemost. 2024 Nov 22:S1538-7836(24)00695-0. doi: 10.1016/j.jtha.2024.11.005.
	38984712	0	Carlin S, Jakovac M, Budaj A, et al. Factor XI inhibition in cardiovascular disease. Pol Arch Intern Med. 2024 Aug 8;134(7-8):16799. doi: 10.20452/pamw.16799. Epub 2024 Jul 9.
	38823454	0	Carlin S, Cuker A, Gatt A, et al. Anticoagulation for Stroke Prevention in Atrial Fibrillation and Treatment of Venous Thromboembolism and Portal Vein Thrombosis in Cirrhosis: Guidance from the SSC of the ISTH. J Thromb Haemost. 2024 May 30:S1538-7836(24)00311-8. doi: 10.1016/j.jtha.2024.05.023.
	38296660	0	Godoy A, Carlin S, Douketis JD. Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time? Eur J Intern Med. 2024 Jan 30:S0953-6205(24)00039-6. doi: 10.1016/j.ejim.2024.01.032.
	38215970	0	Carlin S, Eikelboom J. Restarting anticoagulation after major bleeding in patients with atrial fibrillation. Can J Cardiol. 2024 Jan 10:S0828-282X(24)00019-9. doi: 10.1016/j.cjca.2024.01.008.
	37523701	0	Carlin S, Douketis J. In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level. Ann Intern Med. 2023 Aug;176(8):JC91. doi: 10.7326/J23-0054. Epub 2023 Aug 1.
	37144115	0	Carlin S, Gross PL. Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients. JACC CardioOncol. 2023 Feb 7;5(2):201-202. doi: 10.1016/j.jaccao.2022.12.006. eCollection 2023 Apr.
	37127507	0	Carlin S, Chan NC, Douketis JD. Routine measurement of DOAC concentrations for prognostication and clinical management in acute ischemic stroke: Is it ready for prime time? Eur J Intern Med. 2023 Jul;113:18-19. doi: 10.1016/j.ejim.2023.04.024. Epub 2023 Apr 29.
	37122531	0	Candeloro M, Carlin S, Shapiro MJ, et al. Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review. Res Pract Thromb Haemost. 2023 Mar 28;7(3):100137. doi: 10.1016/j.rpth.2023.100137. eCollection 2023 Mar.
	36601884	0	Carlin S, de Vries TA, Budaj A, et al. Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances. Kardiol Pol. 2022;80(12):1200-1210. doi: 10.33963/KP.a2022.0283.
	34558172	0	Carlin S, Eikelboom JW. Direct oral anticoagulant dose selection: Challenging cases. J Thromb Haemost. 2021 Nov;19(11):2680-2686. doi: 10.1111/jth.15536. Epub 2021 Sep 28.
	34232455	0	Carlin S, Geerts W, Khosravani H. The clot thickens-enhanced integration of stroke and thrombosis training. J Thromb Thrombolysis. 2021 Jul 7. pii: 10.1007/s11239-021-02502-7. doi: 10.1007/s11239-021-02502-7.
	33872825	0	Carlin S, Bond A, Gross P, et al. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thromb Res. 2021 Jun;202:176-181. doi: 10.1016/j.thromres.2021.04.004. Epub 2021 Apr 15.
	28123190	0	Carlin S, Pickering J, Schulman S. Appropriateness of Apixaban Dosing to Prevent Stroke in Patients with Atrial Fibrillation: A Pilot Study. Can J Hosp Pharm. 2016 Nov-Dec;69(6):449-453. doi: 10.4212/cjhp.v69i6.1607. Epub 2016 Dec 23.